Skip to content

Exploration of bile and gut microbiome with their metabolomics in the bile duct diseases

Exploration of bile and gut microbiome with their metabolomics in the bile duct diseases - Gut/Bile microbiome study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000040100
Enrollment
500
Registered
2020-04-08
Start date
2020-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who will undergo endoscopic retrograde cholangioscopy

Interventions

None listed

Sponsors

Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Subjects who will undergo endoscopic retrograde cholangiography 2. 18 years and older 3. Subjects who signed up the consent form of the study.

Exclusion criteria

Exclusion criteria: 1. Abnormal postsurgical anatomy hard to obtain bile sample. 2. Subjects who disagree with the study or withdraw the agreement of the study. 3. Subjects who are incapable of filling out a questionnaire in the study.

Design outcomes

Primary

MeasureTime frame
Clarification of gut and microbiome spectrum along with relevance of short chain fatty acids and bile acids in each bile duct disease

Countries

Japan

Contacts

Public ContactKatsuyuki Miyabe

Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital Department of Gastroenterology

kmiyabe@nagoya2.jrc.or.jp052-832-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026